Literature DB >> 12782778

How valuable is ascitic cytology in the detection and management of malignancy?

R O S Karoo1, T D R Lloyd, G Garcea, H D Redway, G S R Robertson.   

Abstract

INTRODUCTION: Ascitic cytology is often requested in the early stages of ascitic assessment. A review of this practice in a major English teaching hospital is presented.
METHOD: Patients were retrospectively identified using the histopathology and patient administration system between January 1999 and May 2001.
RESULTS: Of 276 samples sent for assessment 35 cases were found to be negative when on further review an intra-abdominal malignancy was present. The malignancy was diagnosed using a radiological modality. The sensitivity of ascitic cytology was found to be 60% with 100% specificity. A delay of up to five days could be incurred awaiting the cytology results before further radiological examinations were undertaken.
CONCLUSION: Too much hope is placed on ascitic cytology to provide the diagnosis at the expense of other investigations. It is recommended that the initial assessment should concentrate on history, examination, and basic tests on ascitic fluid to assess the serum-ascites albumin gradient. Ovarian malignancy is the only tumour type yielding a significant rate of detection from cytology with some prognostic impact. Results should not be awaited before abdominal ultrasound is undertaken. This more directed practice would help reduce unnecessary workload for the pathologist and has resource implications.

Entities:  

Mesh:

Year:  2003        PMID: 12782778      PMCID: PMC1742707          DOI: 10.1136/pmj.79.931.292

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  17 in total

1.  Ascites as a predictor of ovarian malignancy.

Authors:  Jane Shen-Gunther; Robert S Mannel
Journal:  Gynecol Oncol       Date:  2002-10       Impact factor: 5.482

2.  Malignant ascites.

Authors:  Robert E Enck
Journal:  Am J Hosp Palliat Care       Date:  2002 Jan-Feb       Impact factor: 2.500

3.  Diagnostic accuracy of sialic acid in the diagnosis of malignant ascites.

Authors:  A Colli; G Buccino; M Cocciolo; R Parravicini; F Mariani; G Scaltrini
Journal:  Cancer       Date:  1989-03-01       Impact factor: 6.860

4.  Outcome of palliative operations for malignant bowel obstruction in patients with peritoneal carcinomatosis from nongynecological cancer.

Authors:  S L Blair; D Z Chu; R E Schwarz
Journal:  Ann Surg Oncol       Date:  2001-09       Impact factor: 5.344

5.  The prognostic value of peritoneal cytology in ovarian cancer.

Authors:  M Simojoki; M Santala; S Vuopala; A Kauppila
Journal:  Eur J Gynaecol Oncol       Date:  1999       Impact factor: 0.196

6.  Ascitic fluid analysis in malignancy-related ascites.

Authors:  B A Runyon; J C Hoefs; T R Morgan
Journal:  Hepatology       Date:  1988 Sep-Oct       Impact factor: 17.425

7.  Positive effusion cytology as the initial presentation of malignancy.

Authors:  S A Monte; H Ehya; W R Lang
Journal:  Acta Cytol       Date:  1987 Jul-Aug       Impact factor: 2.319

8.  Malignant ascites of unknown origin.

Authors:  Q S Ringenberg; D C Doll; T S Loy; J W Yarbro
Journal:  Cancer       Date:  1989-08-01       Impact factor: 6.860

9.  Malignant ascites. Clinical and experimental observations.

Authors:  R N Garrison; L D Kaelin; R H Galloway; L S Heuser
Journal:  Ann Surg       Date:  1986-06       Impact factor: 12.969

10.  Total discrimination of peritoneal malignant ascites from cirrhosis- and hepatocarcinoma-associated ascites by assays of ascitic cholesterol and lactate dehydrogenase.

Authors:  G Castaldo; G Oriani; L Cimino; M Topa; I Mostarda; L Castellano; C Del Vecchio-Blanco; G Budillon; F Salvatore; L Sacchetti
Journal:  Clin Chem       Date:  1994-03       Impact factor: 8.327

View more
  11 in total

1.  Ascites in Ovarian Carcinoma - Reliability and Limitations of Cytological Analysis.

Authors:  R Živadinović; A Petrić; D Krtinić; J Stevanović Milosević; S Pop Trajković Dinić
Journal:  West Indian Med J       Date:  2015-04-08       Impact factor: 0.171

2.  Young Man With Non-hypertensive Ascites of Unexpected Cause: When Ockham's Razor Is Not Sufficient.

Authors:  Julián Rondón-Carvajal; Jose C Alvarez-Payares; Natalia Arias-Madrid; Jeanneth Echeverri-Villegas; Laura Uribe-Zapata
Journal:  Cureus       Date:  2022-05-27

3.  Image-guided biopsy in patients with suspected ovarian carcinoma: a safe and effective technique?

Authors:  Nyree Griffin; Lee A Grant; Susan J Freeman; Mercedes Jimenez-Linan; Laurence H Berman; Helena Earl; Ahmed Ashour Ahmed; Robin Crawford; James Brenton; Evis Sala
Journal:  Eur Radiol       Date:  2008-08-15       Impact factor: 5.315

4.  Clinicopathological Study of 117 Body Fluids: Comparison of Conventional Smear and Cell Block Technique.

Authors:  Sonal Hemanth Kumar; Sudhamani S; Divya Shetty; Rajiv Rao
Journal:  Curr Health Sci J       Date:  2020-12-31

5.  Peritoneal lymphoma with ascites mimicking portal hypertensive ascites: A case report.

Authors:  En-Shao Liu; Jyh-Seng Wang; Wen-Chi Yang
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.889

6.  Use of the term atypical cells in the reporting of ascitic fluid cytology: A caveat.

Authors:  Radha Ramachandra Pai; Krithika Damodar Shenoy; Jessica Minal; Pooja K Suresh; Shrijeet Chakraborti; Flora D Lobo
Journal:  Cytojournal       Date:  2019-06-28       Impact factor: 2.091

7.  Diffusion-Weighted Magnetic Resonance Imaging as a Noninvasive Parameter for Differentiating Benign and Malignant Intraperitoneal Collections.

Authors:  Paul-Andrei Ștefan; Csaba Csutak; Andrei Lebovici; Georgeta Mihaela Rusu; Carmen Mihaela Mihu
Journal:  Medicina (Kaunas)       Date:  2020-05-01       Impact factor: 2.430

8.  New proposal for the serum ascites albumin gradient cut-off value in Chinese ascitic patients.

Authors:  Cai-feng Jiang; Bin Shi; Jian Shi; Zong-li Yuan; Wei-fen Xie
Journal:  Diagn Pathol       Date:  2013-08-23       Impact factor: 2.644

9.  Case Report: Detection and quantification of tumor cells in peripheral blood and ascitic fluid from a metastatic esophageal cancer patient using the CellSearch (®) technology.

Authors:  Qian Tu; Marcelo De Carvalho Bittencourt; Huili Cai; Claire Bastien; Camille Lemarie-Delaunay; Marie C Bene; Gilbert C Faure
Journal:  F1000Res       Date:  2014-01-15

10.  Diagnostic and prognostic value of SHOX2 and SEPT9 DNA methylation and cytology in benign, paramalignant, and malignant ascites.

Authors:  Maria Jung; Svenja Pützer; Heidrun Gevensleben; Sebastian Meller; Glen Kristiansen; Dimo Dietrich
Journal:  Clin Epigenetics       Date:  2016-03-01       Impact factor: 6.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.